World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
27392
World Ranking
5475
National Ranking
2599

Overview

John E. Sims is affiliated with Amgen, a biotechnology company based in the United States. This association places them within a prominent institution engaged in pharmaceutical research and development.

While detailed information about their main fields of study, subfields, or specific research topics is not provided, their connection to Amgen suggests involvement in biomedical or biopharmaceutical research activities.

No data is available regarding recent papers, frequent co-authors, or publication venues, indicating limited publicly accessible bibliometric records or published works under this name at this time.

There is also no information about book publications or awards won by John E. Sims.

This profile presents the available factual data without assumptions about the scope or impact of their research. The lack of detailed publication or topic records suggests that additional sources may be needed to attain a fuller overview of their scientific contributions.

Best Publications

  • The IL-1 family: regulators of immunity

    John E. Sims;Dirk E. Smith

  • Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

    Katherine A. Fitzgerald;Eva M. Palsson-McDermott;Andrew G. Bowie;Andrew G. Bowie;Caroline A. Jefferies

  • cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

    J E Sims;C J March;D Cosman;M B Widmer

  • Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

    Francesco Colotta;Fabio Re;Marta Muzio;Riccardo Bertini

  • Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

    Slaheddine Marrakchi;Philippe Guigue;Blair R. Renshaw;Anne Puel

  • A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

    C.J. McMahan;J.L. Slack;B. Mosley;D. Cosman

  • The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms

    Bruce Mosley;M.Patricia Beckmann;Carl J. March;Rejean L. Idzerda

  • SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.

    David N Wald;Jinzhong Qin;Zhendong Zhao;Youcun Qian

  • Interleukin 1 signaling occurs exclusively via the type I receptor.

    J E Sims;M A Gayle;J L Slack;M R Alderson

  • Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs

    Jennifer E. Towne;Kirsten E. Garka;Blair R. Renshaw;G. Duke Virca

  • Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor.

    Linda S. Park;Unja Martin;Kirsten Garka;Brian Gliniak

  • The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

    Francesco Colotta;Steven K. Dower;John E. Sims;Alberto Mantovani;Alberto Mantovani

  • Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling

    Teresa L. Born;Elisabeth Thomassen;Timothy A. Bird;John E. Sims

  • Four New Members Expand the Interleukin-1 Superfamily

    Dirk E. Smith;Blair R. Renshaw;Randal R. Ketchem;Marek Kubin

  • Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways.

    Jennifer L. Slack;K. Schooley;Timothy P. Bonnert;Jennifer L. Mitcham

  • Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

    Hal Blumberg;Huyen Dinh;Esther S. Trueblood;James Pretorius

  • IL-1 family nomenclature

    Charles Dinarello;William Arend;John Sims;Dirk Smith

  • Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.

    Jennifer E. Towne;Blair R. Renshaw;Jason Douangpanya;Brian P. Lipsky

  • Cloning the interleukin 1 receptor from human T cells

    J E Sims;R B Acres;C E Grubin;C J McMahan

  • IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP.

    Patricia Parnet;Kirsten E. Garka;Timothy P. Bonnert;Steven K. Dower

Frequent Co-Authors

Steven K. Dower
Steven K. Dower CSL (Australia)
Carl J. March
Carl J. March Amgen (United States)
Alberto Mantovani
Alberto Mantovani Humanitas University
Craig A. Smith
Craig A. Smith Monash University
Dirk M. Anderson
Dirk M. Anderson Washington University in St. Louis
Kenneth H. Grabstein
Kenneth H. Grabstein Corixa Corporation
David Cosman
David Cosman Amgen (United States)
Luke A. J. O'Neill
Luke A. J. O'Neill Trinity College Dublin
Gaby Palmer
Gaby Palmer University of Geneva
Francesco Colotta
Francesco Colotta Mario Negri Institute for Pharmacological Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing John E. Sims

Trending Scientists

Recently Published Articles